Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021989

Sr. VP, New Prod. Strat. & Dev gave up 753 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Kieffer Tara Lynn · Sr. VP, New Prod. Strat. & Dev

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-01 Shares withheld for taxes : show line 1 in the form −753 $9.49 $7,146 39,385 D
Loading xslF345X05/form4.xml…